1620 Investment Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,525
Closed -$9.97K 695
2026
Q1
$9.97K Sell
2,525
-182
-7% -$917 0.01% 469
2025
Q4
$18.3K Hold
2,707
0.01% 404
2025
Q3
$18.9K Sell
2,707
-20
-0.7% -$139 0.01% 396
2025
Q2
$16.7K Hold
2,727
0.01% 415
2025
Q1
$20.7K Hold
2,727
0.02% 378
2024
Q4
$26.2K Hold
2,727
0.02% 360
2024
Q3
$16.1K Hold
2,727
0.01% 424
2024
Q2
$18.9K Buy
+2,727
New +$19.2K 0.01% 399

Other funds holding MDXG

1620 Investment Advisors's MDXG Position: Q2 2026 in Review

1620 Investment Advisors sold out of MiMedx Group (MDXG) in Q2 2026, closing a stake of 2,525 shares — an estimated $9.97K sold.

1620 Investment Advisors first reported a position in MDXG in Q2 2024 and held it in 8 quarters. The position peaked at $26.2K in Q4 2024. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • 1620 Investment Advisors reported no remaining MiMedx Group position as of Q2 2026 after selling out during the quarter.
  • 1620 Investment Advisors sold 2,525 MiMedx Group shares in Q2 2026, an estimated $9.97K.
  • 1620 Investment Advisors first reported a position in MiMedx Group in Q2 2024 and held it in 8 quarters.
  • 1620 Investment Advisors's MiMedx Group position peaked at $26.2K in Q4 2024.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.